Testing effectiveness (Phase 2)Study completedNCT02795858
What this trial is testing
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Who this might be right for
Carcinoid Tumors
Dana-Farber Cancer Institute 43